These cases highlight the high-risk nature of <i>KMT2A</i>-amplified B-ALL, particularly in older adults, where prognosis is poor and linked to <i>TP53</i> variants or <i>CRLF2</i> rearrangement. The gene discussed is CRLF2; the disease is acute lymphoblastic leukemia.